Product NDC: | 52584-115 |
Proprietary Name: | Brevibloc |
Non Proprietary Name: | Brevibloc |
Active Ingredient(s): | 10 mg/mL & nbsp; Brevibloc |
Administration Route(s): | INTRAVENOUS |
Dosage Form(s): | INJECTION, SOLUTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 52584-115 |
Labeler Name: | General Injectables & Vaccines |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA019386 |
Marketing Category: | NDA |
Start Marketing Date: | 20100701 |
Package NDC: | 52584-115-39 |
Package Description: | 1 VIAL, SINGLE-DOSE in 1 BAG (52584-115-39) > 10 mL in 1 VIAL, SINGLE-DOSE |
NDC Code | 52584-115-39 |
Proprietary Name | Brevibloc |
Package Description | 1 VIAL, SINGLE-DOSE in 1 BAG (52584-115-39) > 10 mL in 1 VIAL, SINGLE-DOSE |
Product NDC | 52584-115 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Brevibloc |
Dosage Form Name | INJECTION, SOLUTION |
Route Name | INTRAVENOUS |
Start Marketing Date | 20100701 |
Marketing Category Name | NDA |
Labeler Name | General Injectables & Vaccines |
Substance Name | ESMOLOL HYDROCHLORIDE |
Strength Number | 10 |
Strength Unit | mg/mL |
Pharmaceutical Classes | Adrenergic beta-Antagonists [MoA],beta-Adrenergic Blocker [EPC] |